JSM2026
Back to all people

Phebe Kemmer

Eli Lilly and Company
1 appearance in the program

Sessions & presentations

Methods and Novel Endpoints (Patient-Reported Outcomes & Digital Health Data) in Biomedical Studies
Presentation: Endpoint Sensitivity in Chronic Pain Studies
Contributed Papers · Wed, Aug 5 , 8:30 AM
Co-Author